JP2024500036A5 - - Google Patents

Info

Publication number
JP2024500036A5
JP2024500036A5 JP2023533634A JP2023533634A JP2024500036A5 JP 2024500036 A5 JP2024500036 A5 JP 2024500036A5 JP 2023533634 A JP2023533634 A JP 2023533634A JP 2023533634 A JP2023533634 A JP 2023533634A JP 2024500036 A5 JP2024500036 A5 JP 2024500036A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
double
molecule
stranded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023533634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500036A (ja
Filing date
Publication date
Priority claimed from GBGB2020534.0A external-priority patent/GB202020534D0/en
Application filed filed Critical
Publication of JP2024500036A publication Critical patent/JP2024500036A/ja
Publication of JP2024500036A5 publication Critical patent/JP2024500036A5/ja
Pending legal-status Critical Current

Links

JP2023533634A 2020-12-23 2021-12-23 抱合体 Pending JP2024500036A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2020534.0A GB202020534D0 (en) 2020-12-23 2020-12-23 Conjugate
GB2020534.0 2020-12-23
PCT/EP2021/087570 WO2022136673A1 (en) 2020-12-23 2021-12-23 Conjugate

Publications (2)

Publication Number Publication Date
JP2024500036A JP2024500036A (ja) 2024-01-04
JP2024500036A5 true JP2024500036A5 (cg-RX-API-DMAC7.html) 2024-12-26

Family

ID=74221032

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023533634A Pending JP2024500036A (ja) 2020-12-23 2021-12-23 抱合体

Country Status (5)

Country Link
US (1) US20240352463A1 (cg-RX-API-DMAC7.html)
EP (1) EP4244357A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024500036A (cg-RX-API-DMAC7.html)
GB (2) GB202020534D0 (cg-RX-API-DMAC7.html)
WO (1) WO2022136673A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024081954A2 (en) * 2022-10-14 2024-04-18 Sanegene Bio Usa Inc. Small interfering rna targeting c3 and uses thereof
CN118202054A (zh) * 2023-02-17 2024-06-14 苏州时安生物技术有限公司 一种调节补体C5表达的siRNA、其缀合物和药物组合物及用途
EP4677090A2 (en) * 2023-03-09 2026-01-14 Leal Therapeutics, Inc. Compositions and methods for modulating c3
EP4680740A1 (en) * 2023-03-14 2026-01-21 Argonaute Rna Limited Conjugate comprising a double stranded rna molecule linked to a single stranded dna molecule
AU2024265748A1 (en) * 2023-05-04 2025-10-23 Argonaute RNA Limited Dual silencing
GB2629617B (en) * 2023-05-04 2025-05-14 Argonaute Rna Ltd Dual Silencing
AU2024312039A1 (en) * 2023-06-21 2026-01-22 Changzhou Hansoh Pharmaceutical Co., Ltd. Sirna, conjugate which contain sirna, pharmaceutical composition and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029212A2 (en) 2002-09-25 2004-04-08 University Of Massachusetts In vivo gene silencing by chemically modified and stable sirna
US8859749B2 (en) 2005-03-08 2014-10-14 Qiagen Gmbh Modified short interfering RNA
US8067572B2 (en) * 2005-05-25 2011-11-29 The University Of York Hybrid interfering RNA
EP2845607A1 (en) 2013-09-09 2015-03-11 University of Vienna Antisense oligonucleotides with improved pharmacokinetic properties
EP3865576A1 (en) * 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
EP3307316A1 (en) * 2015-06-12 2018-04-18 Alnylam Pharmaceuticals, Inc. Complement component c5 irna compositions and methods of use thereof
KR20190128674A (ko) * 2017-03-09 2019-11-18 쿄와 기린 가부시키가이샤 Masp2의 발현을 억제하는 핵산
WO2018185252A1 (en) * 2017-04-05 2018-10-11 Silence Therapeutics Gmbh Nucleic acid conjugates
WO2020104669A1 (en) * 2018-11-23 2020-05-28 Silence Therapeutics Gmbh Nucleic acids for inhibiting expression of c3 in a cell
CN114072503A (zh) * 2019-07-02 2022-02-18 阿尔戈诺特Rna有限公司 载脂蛋白b拮抗剂
US20230183694A1 (en) * 2020-03-16 2023-06-15 Argonaute RNA Limited Antagonist of pcsk9

Similar Documents

Publication Publication Date Title
JP2024531728A5 (cg-RX-API-DMAC7.html)
Buchardt et al. Peptide nucleic acids and their potential applications in biotechnology
CA2457528A1 (en) Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina)
US10538763B2 (en) Compounds and methods for modulation of DUX4
Gee et al. Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides
EP2407558A1 (en) Methods for the detection of a single- or double-stranded nucleic acid molecule
JP2010512747A5 (cg-RX-API-DMAC7.html)
JP2019503394A5 (cg-RX-API-DMAC7.html)
JP2002272489A5 (cg-RX-API-DMAC7.html)
JP2020512845A5 (cg-RX-API-DMAC7.html)
JP2010528041A5 (cg-RX-API-DMAC7.html)
Toulme et al. Targeting RNA structures by antisense oligonucleotides
CA2494930A1 (en) Modified forms of interfering rna molecules
JP2014527401A5 (cg-RX-API-DMAC7.html)
JP2010532163A5 (cg-RX-API-DMAC7.html)
RU2020135289A (ru) Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в
WO2003042385A2 (en) Gene silencing using sense dna and antisense rna hybrid constructs
JP2024517607A5 (cg-RX-API-DMAC7.html)
EP2062586A3 (en) Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors
JP2003517283A (ja) プライマーペアの増幅及び配列決定並びにそれらの使用
KR100397274B1 (ko) 개선된 안정성 및 안티센스 효과를 가진 신규한안티센스-올리고
US6087484A (en) Enhancement of ribozyme catalytic activity by A 2'-O-substituted facilitator oligonucleotide
PT1026261E (pt) Aumento da especificidade da amplificação de ácido nucleico através de um ácido nucleico veiculo
JP2022537987A5 (cg-RX-API-DMAC7.html)
JP2008500817A5 (ja) Dnaウイルスのマイクロrna及びそれを阻害する医薬品